|
- Pfizer: One of the worlds premier biopharmaceutical companies
Starting with Charles Pfizer inventing an almond-flavored antiparasite medicine in 1849, our people have always been innovators and trailblazers, committed to finding the next cure
- Careers | Pfizer
We’ve transformed growth and development at Pfizer to ensure that everyone can follow a path to their dream career, whether that’s climbing a traditional ladder or “zig-zagging” their way to a new role
- Our Products: Holding the Promise of a Breakthrough | Pfizer
In this section find an overview of our Pfizer Products and search for information on our most popular Pfizer products Our products are the results of 1500 scientists overseeing more than 500,000 lab tests and over 36 clinical trials before the first prescription
- Opportunities for Early Careers | Pfizer: One of the worlds premier . . .
We’re giving first year MBA students from some of the country’s top-ranking business schools the chance to be future Pfizer leaders This summer program will see you make your mark on challenging business-driving projects, in one of our many United States locations
- New Drug Development Pipeline: Pfizers Medicine, Vaccine Discovery . . .
This section defines all the terms you’ll see throughout the Pfizer Product Pipeline You can tap the (i) wherever you see it in the experience to be brought to this glossary
- History - Pfizer
The Best Get Better—Pfizer and Warner-Lambert merge to form the new Pfizer, creating the world's fastest-growing major pharmaceutical company Learn more about the Pfizer Warner-Lambert merger
- Pfizer’s Purpose, Core Values, and Purpose Blueprint | Pfizer
At Pfizer, we redefine the limits of scientific discovery every day, applying 174 years of life-changing innovations to build a brighter and better future We’ve achieved goals that felt unachievable just years ago—and now we’re asking, “what’s next?”
- Pfizer’s Core Values of Social Responsibility and Philanthropy
Pfizer announces that they have entered into a definitive merger agreement under which Pfizer will acquire Hospira This strategically complementary combination adds a growing revenue stream and a platform for growth for Pfizer’s GEP business
|
|
|